Dubai has approved a major new strategy for its longevity, wellness and advanced health sector, targeting an economic contribution of more than AED 35 billion over the next decade and annual sector growth of around 31%.
The strategy was approved by Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai and Chairman of The Executive Council of Dubai, following the inaugural board meeting of the Dubai Longevity Authority (DLA).
Established in June 2026, the DLA is tasked with developing Dubai as a global hub for healthy longevity. Its mandate covers the sector’s full value chain, including research and development, clinical trials, advanced therapies, manufacturing, healthcare delivery and patient clinics.
The authority is also developing a science-driven regulatory framework for longevity-related therapies and innovations. Its strategy includes an activity-based licensing system, minimum standards and enforcement mechanisms, alongside a Minimum Viable Product programme that will allow selected innovators to test and develop solutions under regulatory supervision.
Beyond healthcare, the initiative is designed to attract international investment, specialised talent, advanced technologies and intellectual property, while creating new opportunities across life sciences, biotechnology and medical innovation.
The strategy supports the objectives of Dubai’s Economic Agenda D33 and Social Agenda 33, including improving quality of life and healthy life expectancy.
With its new regulatory and investment framework, Dubai is positioning longevity as an emerging economic and healthcare sector, connecting scientific research with clinical development, innovation and global markets.
